S ystems immunology is a growing field that attempts to integrate high-throughput experiments with sophisticated computational analysis and modeling approaches. 1 In the field of systems immunology, single-cell transcriptomic profiling (RNA-seq) is an experimental technique that has proven effective for delineating molecular heterogeneity within immune cell subtypes. 2 Large-scale genomic techniques like single-cell RNA-seq are often described as hypothesis generating. One of the challenges of applying these experimental techniques is shortening the progression from hypothesis generation to hypothesis testing. Recently, Gaublomme and colleagues reported an approach to the analysis of single-cell RNA-seq of Th17 cells. They were able to identify and subsequently validate several novel regulators of pathogenicity in Th17 cells using a method that could be applied to the analysis of genomic data from other immune cell populations. 3 Th17 cells comprise a subtype of CD4 + T cells that express the cytokine IL-17. With the help of this signature cytokine, these powerful inflammatory cells play an important role in the clearance of a number of bacterial and fungal pathogens. 4 Th17 cells have also been implicated in the development of autoimmune syndromes including psoriasis, Crohn's disease and rheumatoid arthritis. 4 Previous experiments have identified important functional heterogeneity within this otherwise monolithic population. These experiments differentiated naive CD4 + T cells into Th17 cells under various conditions in vitro. They then showed that these differentiated cells displayed distinct phenotypes in vivo following adoptive transfer. 5 Single-cell RNA-seq is a method of transcriptomic profiling applied to individual cells that have been isolated using fluorescenceactivated cell sorting (FACS). This method has proven useful for profiling immune cell populations and identifying previously unrecognized heterogeneity within them. For example, single-cell RNA-seq has been used to predict the fate of CD8 + T cells early in an immune response. 6 Likewise, single-cell RNA-seq was instrumental in identifying paracrine signaling between dendritic cells exposed to pathogen-like stimuli. 7 Application of single-cell RNA-seq to Th17 cell populations is promising because identification of heterogeneous gene expression within these populations may yield new information about potential targets for pharmacologic intervention aimed at modulating their proinflammatory role in autoimmunity. The approach reported by Gaublomme and colleagues to the analysis of single-cell RNA-seq of different populations of Th17 cells incorporated functional annotation using novel gene signatures and provided insight into transcriptional heterogeneity within these populations. Importantly, their investigations led to the validation of new molecular targets driving Th17 inflammation.
As introduced above, investigators have used different combinations of cytokines to induce the formation of Th17 cells from naive CD4 + T cells. These cytokine cocktails produce distinct Th17 cellular populations with diverse cytokine profiles and functional activities in vivo. For example, Th17 cells induced from naive CD4 + cells by exposure to IL-6, IL-1β and TGF-β1 express Maf and Ahr messenger RNA (mRNA), whereas cells induced by exposure to IL-6, IL-1β and IL-23 express Tbx21 and Hlx mRNA. This latter population generates significantly more central nervous system (CNS) inflammation compared to the former following adoptive transfer in a mouse model of autoimmune encephalomyelitis (EAE). 5 Gaublomme and colleagues applied single-cell RNA-seq to the analysis of in vitro-polarized Th17 cells induced using IL-6 and TGF-β1 or IL-6, IL-1β and IL-23 as well as in vivo-differentiated Th17 cells isolated from either the CNS or lymph nodes (LNs) during a mouse model of EAE.
In order to enrich the analysis of their RNA-seq experiments, the investigators used principal component analysis (PCA) and applied several new techniques for functional annotation. PCA is a method of visualizing complex genomic data that represents the relative similarity of input variables as a distance in PCA space (see Figure 1 for further explanation). 8 For an RNA-seq experiment, the first principal component (PC1) represents the linear combination of gene expression that encompasses the most variation in the data.
Gaublomme and colleagues used published sources of expression data in immune cells to generate signatures for several immune cell states. Each signature consisted of a list of positive and negative genes that correlated strongly with that state, and was used to assign a signature score to every cell. The investigators then determined how well the corresponding signature scores correlated with PC1 or PC2. They represented the signatures that correlated significantly as vectors on their PCA. Thus, they were able to create a sort of annotation of the PCA space that could help them to understand what was driving the phenotypic heterogeneity in their cellular populations. The investigators found that for Th17 cells isolated during EAE, the signatures 'Memory vs naïve (CD4),' 'Th1' and 'Genes in covariation with proinflammatory vs regulatory module' correlated with expression profiles of cells isolated from the CNS. The signature 'Naive vs memory (CD8)' correlated with cells isolated from the LNs. The signatures 'Memory vs effector (KLRG+) (CD8),' 'Wnt' and 'Effector vs memory (CD4)' correlated with a mixtures of cells isolated from the CNS and LNs. Thus, the investigators were able to assign functional meaning to the observed heterogeneity of expression within the Th17 cell populations. Specifically, they used the various immune cell signatures to divide their PCA figure into five areas called Voronoi regions based on the proximity between the cells and the signatures. They assigned each region in the figure a characteristic immune cell state corresponding to progression from a 'Th17 self-renewing' state in the LNs to a 'Th17/ Th1-like memory' state in the CNS. Several genes that were enriched in either PC1 or PC2 corresponded to targets of transcription factors that had not previously been identified as important drivers of either the Th17 selfrenewing phenotype (associated with cells isolated from LNs) or the pathogenic effector phenotype (associated with cells isolated from the CNS).
A similar PCA-based analysis was performed with in vitro-polarized cells, and heterogeneity was observed within cells exposed to the same cytokine cocktails. Cells exposed to IL-6, IL-1β and IL-23 demonstrated widely varying patterns of expression. Some were highly correlated with a 'Pathogenicity' signature, while others overlapped with cells exposed to IL-6 and TGF-β1. Similarly, among cells exposed to the latter cocktail were cells highly correlated with non-pathogenic signatures, such as 'In vivo Th17 self-renewing.' These results suggest that under precisely controlled differentiation conditions, the cellular phenotypes of Th17 cells are heterogeneous. At the same time, it is apparent that the conditions used in this experiment do not fully recapitulate the phenotypes observed in the in vivo EAE model. Indeed, one avenue of future study may be refining the in vitro model with the aim of producing Th17 cell differentiation that more closely resembles the transcriptional state observed in LNs vs CNS in the EAE model.
The investigators proceeded to construct modules of genes that co-varied either positively or negatively with a set of Th17 cytokines known to promote inflammation. This analysis permitted identification of new Th17 cell pathogenicity regulators. The candidates included Gpr65, Plzp and Cd5l (positively correlated with the Th17 pro-inflammatory module) and Toso and Foxp1 (negatively correlated with the pro-inflammatory module). Using transgenic mice, Gpr65, Plzp, Toso and Cd5l were determined to be relevant genes for the pathogenic Th17 cell state. 9 For example, when Toso − / − cells were differentiated in vitro, fewer IL-17A producing cells were observed than in wild-type (WT) cells. Likewise, in their companion paper, the authors showed that loss of CD5L causes non-pathogenic Th17 cells to convert to pathogenic cells. Adoptive transfer of WT vs Cd5l − / − in vitro-differentiated Th17 cells revealed that mice receiving Cd5l − / − cells Figure 1 Principal component analysis (PCA) can be used to represent in two dimensions the most important distinguishing features of a large genomic data set such as a single-cell RNA-seq experiment (a). In their paper, Gaublomme and colleagues used signatures based on published immune cell expression data in order to annotate the PCA space of their in vivo-differentiated Th17 cells, and used covariation with a Th17 cell pathogenicity signature to identify new potential regulators of pathogenicity in Th17 cells (b).
developed EAE, whereas mice that received WT cells did not.
It is promising that Gaublomme and colleagues were able to make meaningful biological conclusions using signatures generated largely from published lymphocyte and immune cell-gene expression data. In this way, they have shown that although their single-cell genomic approach is largely descriptive, it is at the same time powerful and readily applicable to the generation of new hypotheses. Gaublomme and colleagues' paper highlights a major strength of single-cell RNA-seq: the ability to tease apart the heterogeneity within FACS-sorted immune cell populations. They identified and validated several novel Th17 regulators, which should be investigated further as drug targets for Th17-related disease states. Gaublomme and colleagues' approach for using highly dimensional data produced by single-cell RNA-seq to explore cellular pathogenic function could be applied to myriad subsets of immune cells.
